news Monoclonal antibodies prevent COVID-19 inflammation in macaques 2 November 2021 | By Anna Begley (Drug Target Review) Neutralising monoclonal antibodies protected aged macaque monkeys from SARS-CoV-2 and reduced inflammation, including in cerebrospinal fluid, a new study has shown.
news Stem cells used to enhance immune response to HIV in primates 24 June 2021 | By Victoria Rees (Drug Target Review) In non-human primates, researchers have found that mesenchymal stem cells were effective at strengthening the immune response to HIV.
news Rhesus macaque model of Alzheimer’s disease developed 19 March 2021 | By Victoria Rees (Drug Target Review) Scientists have developed a model of the early stages of Alzheimer's disease in rhesus macaques to better test new treatments.
news Rhesus macaques with SARS-CoV-2 develop promising immune response 25 January 2021 | By Victoria Rees (Drug Target Review) A study has shown that the immune response of rhesus macaques with SARS-CoV-2 could be reproduced with a vaccine.
news Non-hallucinogenic version of ibogaine could treat addiction and depression 10 December 2020 | By Victoria Rees (Drug Target Review) A non-hallucinogenic version of the psychedelic drug ibogaine could treat psychiatric disorders, pre-clinical trials have shown.
news Researchers identify potential drug target for depression in primates 15 August 2019 | By Nic Losardo (Drug Target Review) A study has discovered a molecule key in neuronal growth that could be used as a drug target to treat anxiety-related diseases.
